lower price 98.5% Light yellow crystalline powder Levofloxacin
7 Inquiries
100986-85-4
2026-09-26
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionKeywords
LEVOFLOXACIN HEMIHYDRATE;(3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyr
(s)-ofloxacin;7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylicacid,2,3-dihydro-9-fluoro-3-m;dr3355;h
Levofloxacin
Quick DetailsProName:lower price 98.5% Light yellow crystalline powder Levofloxacin
CasNo:100986-85-4
Molecular Formula:C18H20FN3O4
Appearance:Light yellow crystalline powder
Application:used to treat severe or life-threatening bacterial infections
DeliveryTime:Prompt shipment
PackAge:25kg/drum
Port:Hangzhou or Shanghai,China
ProductionCapacity:Metric Ton/Day
Purity:98.5%
Storage:Cool and dry
Transportation:BY SEA AIR OR EXPRESS
LimitNum:100 Gram
Grade:Pharma Grade
SuperioritySpecific rotation :-92.0°~ -109.0°
Related substance: ≤0.5%
Loss on drying: ≤3.0%
Limit of(R)…
DetailsSpecific rotation :-92.0°~ -109.0°
Related substance: ≤0.5%
Loss on drying: ≤3.0%
Limit of(R)-olfx: ≤ 1.0%
Residue on ignition: ≤ 0.2%
Heavy metals :≤ 0.002%
ECHEMI Editorial ReferenceLevofloxacin, a synthetic fluoroquinolone, is an antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.Target: AntibacterialLevofloxacin reduced bacterial load compared with placebo by 4.9-fold (95% confidence interval, 1.4-25.7; P=0.02) at day 7 but had no effect at any point on any marker of neutrophilic airway inflammation. In patients with a baseline bacterial load of more than 10(6) cfu/mL, levofloxacin treatment was associatedBasic Info-
Product Name:
Levofloxacin
Other Name:7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-,(3S)-;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-,(S)-;(3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid;(-)-Ofloxacin;(S)-Ofloxacin;DR 3355;(S)-(-)-Ofloxacin;Levofloxacin;HR 355;RWJ 25213-097;Tavanic;Levaquin;Cravit;Quixin;Oftaquix;Loxof;MP 376;Unibiotic;Venaxan;Levoflox;Lexoflon;Iquix;Quinsair
CAS No.:100986-85-4
Molecular Formula:C18H20FN3O4
InChIKeys:InChIKey=GSDSWSVVBLHKDQ-JTQLQIEISA-N
Molecular Weight:361.36800
Exact Mass:361.37
EC Number:600-146-0
HScode:2934999090
Categories:
Characteristics-
PSA:
75.01000
XLogP3:-0.4
Appearance:Solid
Density:1.48 g/cm3
Melting Point:225-227 °C (decomp)
Boiling Point:571.5ºC at 760 mmHg
Flash Point:299.4ºC
Refractive Index:1.670
Water Solubility:H2O: Insoluble
Storage Conditions:Store at 0-5ºC
Vapor Pressure:9.8X10-13 mm Hg at 25 deg C (est)
Specific rotation:Specific optical rotation: -76.9 deg at 23 °C/D ( c = 0.385 in 05N NaOH)
PKA:6.25None
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Skin sensitization, Category 1
Respiratory sensitization, Category 1
Reproductive toxicity, Category 2
Reproductive toxicity, Additional category for effects on or via lactation
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H317 May cause an allergic skin reaction
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled
H361 Suspected of damaging fertility or the unborn child
H362 May cause harm to breast-fed children
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P272 Contaminated work clothing should not be allowed out of the workplace.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P284 [In case of inadequate ventilation] wear respiratory protection.
P203 Obtain, read and follow all safety instructions before use.
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P263 Avoid contact during pregnancy and while nursing.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P333+P317 If skin irritation or rash occurs: Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P342+P316 If experiencing respiratory symptoms: Get emergency medical help immediately.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Inquiry History7 Inquiries
Country Product Purchase Quantity Date Posted 
South Korea
Levofloxacin Power/ Levofloxacin HCL/ Levofloxacin Hemihydrate(100986-85-4)
1 G Jun 9, 2026 
Canada
Levofloxacin hydrochloride
60 G Sep 27, 2025 
India
levofloxacin
25 KG May 20, 2025
India
levofloxacin
25 KG May 19, 2025 
Italy
Levofloxacin
1 KG Jan 24, 2024 
United Kingdom
Levofloxacin
1 KG Mar 23, 2026 
Bangladesh
Levofloxacin
100 KG Nov 28, 2024 Post an enquiry for this product
